Seiji Shiraishi Selected Research

Neoplasms (Cancer)

1/2017	Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.
1/2017	Therapeutic potential of ghrelin and des-acyl ghrelin against chemotherapy-induced cardiotoxicity.
10/2014	Relief of cancer pain by glycine transporter inhibitors.
2/2014	New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line.
1/2014	Palliation of bone cancer pain by antagonists of platelet-activating factor receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seiji Shiraishi Research Topics

Disease

10	Pain (Aches) 04/2020 - 03/2004
8	Neuralgia (Stump Neuralgia) 01/2022 - 03/2004
5	Hyperalgesia 07/2019 - 03/2004
5	Neoplasms (Cancer) 01/2017 - 01/2014
3	Bone Neoplasms (Bone Cancer) 08/2015 - 01/2014
3	Cancer Pain 04/2015 - 01/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 04/2020 - 07/2019
2	Cachexia 01/2017 - 02/2014
2	Anorexia 01/2017 - 02/2014
2	Subacute Sclerosing Panencephalitis (SSPE) 10/2003 - 07/2003
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 04/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2019
1	Cardiotoxicity 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Dyspepsia (Indigestion) 11/2016
1	Hyperammonemia 11/2016
1	Weight Gain 08/2016
1	Weight Loss (Weight Reduction) 02/2014
1	Constipation 01/2014
1	Inflammation (Inflammations) 09/2013
1	Blister (Bulla) 02/2012
1	Necrosis 02/2012
1	Muscular Atrophy (Muscle Atrophy) 09/2009

Drug/Important Bio-Agent (IBA)

5	Analgesics (Analgesic Drugs)IBA 01/2017 - 03/2004
3	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2014
3	Platelet Activating FactorIBA 01/2017 - 01/2014
2	Pharmaceutical PreparationsIBA 07/2019 - 11/2016
2	GhrelinIBA 01/2017 - 01/2017
2	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 01/2017 - 01/2014
2	liu-jun-zi-tangIBA 01/2017 - 02/2014
2	EnzymesIBA 01/2017 - 01/2014
2	Morphine (MS Contin)FDA LinkGeneric 10/2014 - 01/2014
2	Small Interfering RNA (siRNA)IBA 10/2014 - 01/2014
2	Opioid Analgesics (Opioids)IBA 10/2014 - 01/2014
2	Lidocaine (Xylocaine)FDA LinkGeneric 02/2012 - 02/2012
2	OrexinsIBA 05/2005 - 03/2004
2	Ribavirin (Virazole)FDA LinkGeneric 10/2003 - 07/2003
1	Myelin Basic ProteinIBA 01/2022
1	Sodium Channels (Sodium Channel)IBA 04/2020
1	taxaneIBA 04/2020
1	A Kinase Anchor ProteinsIBA 07/2019
1	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 07/2019
1	Carboplatin (JM8)FDA LinkGeneric 07/2019
1	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 07/2019
1	Pattern Recognition ReceptorsIBA 01/2019
1	Histocompatibility Antigens Class IIBA 01/2019
1	lysophosphatidic acidIBA 01/2017
1	ABT 491IBA 01/2017
1	des-n-octanoyl ghrelinIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Free RadicalsIBA 01/2017
1	Hormones (Hormone)IBA 01/2017
1	AnthracyclinesIBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 11/2016
1	SaltsIBA 11/2016
1	Amino Acids FDA Link 11/2016
1	Arginine (L-Arginine)FDA Link 11/2016
1	Olanzapine (Zyprexa)FDA Link 08/2016
1	Antipsychotic Agents (Antipsychotics)IBA 08/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2016
1	Capsaicin (Zostrix)FDA Link 02/2016
1	TRPV Cation ChannelsIBA 02/2016
1	Tramadol (K315)FDA LinkGeneric 04/2015
1	ALX 1393IBA 10/2014
1	N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA 10/2014
1	Glycine Plasma Membrane Transport ProteinsIBA 10/2014
1	DNA Transposable Elements (Element, IS)IBA 10/2014
1	StrychnineIBA 10/2014
1	Serum AlbuminIBA 02/2014
1	platelet activating factor receptorIBA 01/2014
1	WEB 2086 (apafant)IBA 01/2014
1	TCV 309IBA 01/2014
1	BN 50739IBA 01/2014
1	Formaldehyde (Formol)FDA Link 09/2013
1	AdrenomedullinIBA 09/2013
1	Nerve Growth Factor (NGF)IBA 02/2012
1	Substance PIBA 12/2010
1	F-Box ProteinsIBA 09/2009
1	MyogeninIBA 09/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2007
1	ProstaglandinsIBA 01/2007
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2007
1	SC 560IBA 01/2007
1	Streptozocin (Streptozotocin)FDA Link 01/2007
1	1- ((4- methylsulfonyl)phenyl)- 3- trifluoromethyl- 5- (4- fluorophenyl)pyrazoleIBA 01/2007

Therapy/Procedure

3	Therapeutics 01/2017 - 07/2003
2	Ligation 01/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 07/2019 - 01/2017
2	Spinal Injections 10/2014 - 01/2014
2	Transplantation 10/2014 - 01/2014
2	Oral Administration 10/2014 - 02/2014
1	Intravenous Administration 01/2022
1	Kampo Medicine (Kampo) 01/2017
1	Molecular Targeted Therapy 01/2017
1	Oral Medicine 11/2016